Brief: Immix Biopharma Inc- Co Entered Into Securities Purchase Agreement With Certain Accredited Investor
Aug 22 (Reuters) - Immix Biopharma Inc IMMX.O :
* IMMIX BIOPHARMA INC- ON AUG 21, CO ENTERED INTO SECURITIES
PURCHASE AGREEMENT WITH CERTAIN ACCREDITED INVESTOR
* IMMIX BIOPHARMA- PURSUANT TO DEAL, AGREED TO SELL AND
ISSUE TO
PURCHASER IN PRIVATE PLACEMENT TRANSACTION OF 3,241,076 SHARES
OF CO’S COMMON STOCK
* IMMIX BIOPHARMA- SEES TO RECEIVE GROSS PROCEEDS OF
APPROXIMATELY
$10 MILLION FROM THE PRIVATE PLACEMENT AND NET PROCEEDS OF
APPROXIMATELY $9.55 MILLION
Further company coverage: IMMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary